HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

med.21724, Compound Benztropine

HCID 1201549
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
86-13-5
Standard SMILES
CN1[C@@H]2CC[C@H]1CC(OC(c1ccccc1)c1ccccc1)C2
InChIKey
GIJXKZJWITVLHI-PMOLBWCYSA-N
Molecular formula
C21H25NO
Average molar mass
307.4 g/mol
Monoisotopic mass
307.19361442

Overview

Benzatropine is tropane in which a hydrogen at position 3 is substituted by a diphenylmethoxy group (endo-isomer). An acetylcholine receptor antagonist, it is used (particularly as its methanesulphonate salt) in the treatment of Parkinson's disease, and to reduce parkinsonism and akathisia side effects of antipsychotic treatments. It has a role as a oneirogen, an antiparkinson drug, a muscarinic antagonist, a parasympatholytic and an antidyskinesia agent.

Names & identifiers

Preferred name
med.21724, Compound Benztropine
IUPAC
(1R,5S)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane
English name
benzatropine
Molecular formula
C21H25NO
Molecular weight
307.43

Names & synonyms

med.21724, Compound BenztropineRefChem:1088905benztropineBenzatropine86-13-5CobrentinTropine benzohydryl etherBenzatropinaBenzatropinumBenztropinumCogentineAkitan
Show more names
BenaztropineC06846NISTC86135exo-BenztropineGIJXKZJWITVLHI-PMOLBWCYSA-N(1S,5R)-3α-(Diphenylmethoxy)tropane
3endo-benzhydryloxytropaneBenzatropinum [INN-Latin]Benzatropina [INN-Spanish]Cogentinol3alpha-(diphenylmethoxy)tropaneDTXSID9022659HSDB 3014NK 02

Database identifiers

CAS
86-13-5
PubChem CID
1201549
DTXSID
DTXSID9022659
ChEMBL
CHEMBL1618180、CHEMBL438151
ChEBI
CHEBI:3048
UNII
1NHL2J4X8K
Nikkaji
J232.148C、J4.933F

Properties

Computed structural propertiesFilling in

XLogP
4.5
Topological polar surface area
12.5 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
4
Heavy atoms
23
Formal charge
0
Complexity
340

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Human DrugsPharmaceuticals
Melting Point135ºC
Dissociation Constants10
Collision Cross Section180.8 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Physicochemical properties

Boiling point
447.93 °C · 447.93°C (rough estimate)
Density
1.0505 · 1.0505 (rough estimate)
refractive index
1.5614 · 1.5614 (estimate)
pka
10.54 · 10.54±0.40(Predicted)
Henry's Law Constant
4.5 · 4.5×103 mol/(m3Pa) at 25℃, HSDB (2015)
FDA UNII
1 NHL2J4X8K · 1NHL2J4X8K

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Toxicity
LD50 scu-mus: 60 mg/kg JMPCAS 4,215,61
Hazardous Substances Data
86-13-5(Hazardous Substances Data)

Chemistry & industry

Pharmacology

Protein BindingAbout 95% of the administered dose of benztropine is found bound to plasma proteins.
Pharmacodynamics · 1 item

The inhibition of dopamine reuptake by benztropine produces a dose-dependent increase of dopamine in the nerve terminal of the dopaminergic system. Clinically the activity of benztropine is observed after 1-2 hours of oral administration and after a few minutes of intramuscular administration with a last-longing effect of about 24 hours. Reports have indicated that benztropine has a very large sedative effect. The antihistaminic effect of benztropine is very similar to the effect found in [pyrilamine] and the anticholinergic activity was found to be equal to [atropine] _ex vivo_ and of about 50% activity _in vivo_.

Mechanism of Action · 1 item

Benztropine is an agent with anti-muscarinic and antihistaminic effects. Its main mechanism of action is presented by the selective inhibition of dopamine transporters but it also presents affinity for histamine and muscarine receptors. It is widely known that benztropine is a potent inhibitor of presynaptic carrier-mediated dopamine transport. As well, it is known to be an analog of atropine and hence, it has a large affinity for muscarinic receptors M1 in the human brain. Once bound, benztropine blocks the activity of the muscarinic receptors mainly in the striatum. The increased advantage of benztropine lays on the antagonism of acetylcholine activity which corrects the imbalance between dopamine and acetylcholine in Parkinson patients.

Biological Half-LifeThe elimination half-life of benztropine is very variable and it is reported to be of around 36 hours.
Metabolism/MetabolitesBenztropine has been shown to undergo metabolism mainly marked by N-oxidation, N-dealkylation and ring hydroxylation. The extensive metabolism of benztropine produces eight phase-I metabolites plus four glucuronide conjugates.
Absorption, Distribution and Excretion · 4 items

Oral administration of 1.5 mg of benztropine is slowly absorbed in the gastrointestinal tract and it reaches a peak concentration of 2.5 ng/ml in about 7 hours. It has an approximate oral bioavailability of 29%.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ATC code
4 AC01 · N04AC01
EPA Substance Registry System
8 · 8-Azabicyclo[3.2.1]octane, 3-(diphenylmethoxy)-8-methyl-, (3-endo)- (86-13-5)
Hazardous Substances Data
86 · 86-13-5(Hazardous Substances Data)
Toxicity
50 scu-mus: · LD50 scu-mus: 60 mg/kg JMPCAS 4,215,61

Benztropine is mainly excreted in the urine but it is also found in the feces unchanged.

Benztropine is expected to present a large volume of distribution between 12-30 L/kg.

Extensive pharmacodynamic or pharmacokinetic studies have not been performed.

Uses & manufacturing

Use ClassificationPharmaceuticals
Applications · 3 items

DescriptionBenztropine, with the chemical formula 3alpha-diphenylmethoxytropane, is a tropane-based dopamine inhibitor used for the symptomatic treatment of Parkinson's disease. It is a combination molecule between a tropane ring, similar to cocaine, and a diphenyl ether from the dialkylpiperazines determined to be a dopamine uptake inhibitor since 1970.

UsesBenzatropine is used to reduce extrapyramidal side effects of antipsychotic treatment. Benzatropine is also a second-line drug for the treatment of Parkinson's disease. It improves tremor, and may alleviate rigidity and bradykinesia.Benzatropine is also sometimes used for the treatment of dystonia, a rare disorder that causes abnormal muscle contraction, resulting in twisting postures of limbs, trunk, or face.

UsesAntiparkinsonian.

Additional notes · 1 item

DefinitionChEBI: Tropane in which a hydrogen at position 3 is substituted by a diphenylmethoxy group (endo-isomer). An acetylcholine receptor antagonist, it is used (particularly as its methanesulphonate salt) in the treatment of Parkinson's disease, and to re uce parkinsonism and akathisia side effects of antipsychotic treatments.